Драйв на Ferrari F50: красно-желтый дуэт против Кена Блока.

12 апреля 2013
(0 голосов)
Author :  

 

 

Похоже, кое-кого, имеющего в своем распоряжении сразу две Ferrari F50, здорово разозлил Кен Блок с его выкрутасами. И вот что получилось в итоге...

Comment

  • Latasha Latasha 12.04.2013

    I'm curious to find out what blog system you're working with?

    I'm having some small security problems with my latest site and I would
    like to find something more safe. Do you have
    any solutions?

  • Monte Monte 12.04.2013

    Paragraph writing is also a excitement, if you be familiar with then you can write or else it is
    difficult to write.

  • polio virus polio virus 12.04.2013

    Rituximab (a humanized anti-CD20 monoclonal antibody) is a useful therapy for Epstein-Barr virus-related post
    transplant lymphoproliferative disease (EBV-PTLD). Nonetheless, hypogammaglobulinemia is a complication related to this remedy.1,2 Little is known about the duration and severity of rituximab-induced low serum immunoglobulin (Ig)
    status. EBV-PTLD. One in every of three patients reported by Verschuuren et
    al1 died of invasive aspergillosis because of hypogammaglobulinemia after 7 months of rituximab remedy.
    Tax calculation shall be finalised throughout checkout. Get
    time restricted or full article access on ReadCube.
    All prices are Net costs. Verschuuren EA, Stevens SJ, van Imhoff GW et al.
    Therapy of posttransplant lymphoproliferative illness with rituximab: the remission, the relapse,
    and the complication. Quartier P, Brethon B, Philippet P et al.
    Remedy of childhood autoimmune haemolytic anaemia with rituximab.
    Castagnola E, Dallorso S, Faraci M et al. Long-lasting
    hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-associated publish-transplant lymphoproliferative disease preemptive therapy.
    Imashuku S, Naya M, Tamura S et al. Effectiveness of rituximab for chemotherapy-resistant a number of tumoral B-LPD
    in a haematopoietic stem cell recipient. Faye A, Quartier P, Reguerre Y et al.
    Chimaeric anti-CD20 monoclonal antibody (rituximab) in publish-transplant B-lymphoproliferative disorder following
    stem cell transplantation in children. Esser JWJ, Niesters
    HGM, van der Holt B et al. Prevention of Epstein-Barr virus-lymphoproliferative illness by molecular monitoring
    and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Kuehnle I, Huls MH, Liu
    Z et al. CD20 monoclonal antibody (rituximab) for
    therapy of Epstein-Barr virus lymphoma after hemopoietic stem cell transplantation. Imashuku,
    S., Teramura, T., Morimoto, A. et al. Prolonged hypogammaglobulinemia following
    rituximab therapy for post transplant Epstein-Barr virus-associated lymphoproliferative illness.

  • design brand identity pdf design brand identity pdf 12.04.2013

    I was wondering if you ever thought of changing the page
    layout of your site? Its very well written; I love what youve got to say.
    But maybe you could a little more in the way of content so people could connect with it better.
    Youve got an awful lot of text for only having 1 or 2 pictures.
    Maybe you could space it out better?

  • Ellie Ellie 12.04.2013

    Hello Dear, are you really visiting this website regularly,
    if so after that you will without doubt obtain good knowledge.

  • Junko Junko 12.04.2013

    Thanks for your marvelous posting! I seriously enjoyed reading it,
    you may be a great author. I will remember to bookmark your blog and may come back at some point.

    I want to encourage yourself to continue your great work, have a nice morning!

  • Wilma Wilma 12.04.2013

    I like the valuable info you supply on your articles.
    I will bookmark your blog and check once more here regularly.
    I'm rather certain I will be told many new stuff proper here!
    Best of luck for the following!

  • Florian Florian 12.04.2013

    When some one searches for his essential thing, therefore he/she desires to be available that in detail, thus that thing is maintained over here.

  • Marjorie Marjorie 12.04.2013

    First off I want to say superb blog! I had a quick question that
    I'd like to ask if you don't mind. I was curious to know how
    you center yourself and clear your mind prior to writing. I've had
    a hard time clearing my mind in getting my ideas out.
    I truly do enjoy writing but it just seems like the first 10 to 15 minutes
    are lost just trying to figure out how to begin. Any ideas
    or hints? Appreciate it!

  • Barney Barney 12.04.2013

    I want to to thank you for this good read!! I absolutely loved every
    little bit of it. I've got you book marked to look
    at new things you post…

Leave your comment

Убедитесь, что Вы ввели всю требуемую информацию, в поля, помеченные звёздочкой (*). HTML код не допустим.

 

Автомобильное Бюро Sport-Engine начало свою работу весной 2010 года – и с тех пор мы стараемся предоставлять нашим клиентам и читателям максимально полную и интересную информацию. Автомобили, процесс их создания, жизни и борьбы на гоночных трассах, история и легендарные личности мира моторов, тренды, ощущения от вождения – вот то, чем живем мы и чем готовы поделиться с Вами.

Если стиль и качество нашей работы вызвали у Вас интерес в плане сотрудничества, пишите на bugaev@sport-engine.com

Искренне надеюсь, что Вам у нас понравится.

Юрий Бугаев, основатель и руководитель Автомобильного Бюро Sport-Engine